Cancer IBM Watson has identified therapies for 323 cancer patients that went overlooked by a molecular tumor board. Researchers said next-generation genomic sequencing is “evolving too rapidly to rely solely on human curation” when it comes to targeting treatments.

IBM Watson has identified therapies for 323 cancer patients that went overlooked by a molecular tumor board. Researchers said next-generation genomic sequencing is “evolving too rapidly to rely solely on human curation” when it comes to targeting treatments.